Author | Barbara Boughton


Lower Dose Chemotherapy Plus Radiation Offers Favorable Prognosis in Hodgkin’s Lymphoma Patients

December 05, 2010

Patients with early-stage Hodgkin’s lymphoma and a favorable prognosis can be treated with less intensive chemotherapy and radiotherapy regimens without affecting outcomes. This is the first study to show that less intensive therapy can be used without sacrificing benefits, according to lead author Andreas Engert, MD, and colleagues.

Survey reveals the general public knows little about lymphoma

November 23, 2010

The saying that “knowledge is power” holds especially true when it comes to a lymphoma diagnosis, and there are best practices for clinicians who want to fully educate their patients. Presentations at ASH 2010 offer data and advice on how to approach&#151and improve&#151education efforts among clinicians and patients.

Survivors of Hodgkin's lymphoma undergo multiple followup CT scans without deriving benefit

October 20, 2010

Canadian researchers also find that patients are not having recommended cancer screening studies done on a regular basis.

Zoledronic acid plus standard therapy offers anticancer effect in multiple myeloma

September 02, 2010

Combined with first-line chemotherapy, intravenous delivery therapy also confers a survival benefit over oral bisphosphonates. Gareth J. Morgan, MD, PhD, lead investigator of the Medical Research Council Myeloma IX study, will share additional trial results at ASH 2010.